Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fein, US
Brian T. Fein, Tamarac, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080268793 | ARRANGEMENT FOR VARIABLE BASS REFLEX CAVITIES - A modified housing in a portable product ( | 10-30-2008 |
Harry Fein, Nokomis, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20120096955 | Combination Ultrasensitive Force Transducer and Grabbing Device for Force and Strain Measurement from Single Cells - The scientific characterization of cellular contractility and cell movement, such as muscle function in particular is, to a large extent, carried out on intact tissue preparations for example using whole intact muscles from animals. Typical indices of muscle function may include isometric force, contractility under external force (load) and spatio-temporal determination of internal calcium concentration under strictly controlled conditions of length and applied force. The major advance of the described apparatus is that the common characterization of cellular contractility can be performed on a single cell rather than an entire tissue or whole animal. As such the apparatus described improves on and eliminates known limitations of currently considered state-of-the-art approaches. | 04-26-2012 |
Jacques Fein, Elkridge, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20120046863 | ORBIT COVARIANCE, ESTIMATION AND ANALYSIS TOOL - Improved orbit/covariance estimation and analysis (OCEAN) system and method are presented utilizing ground station observations collected from satellites passing overhead to estimate the positions, velocities, and other parameters of multiple satellites using weighted least squares (WLS) batch and/or Kalman filter smoothing (KFS) estimation algorithms to estimate each parameter, with or without a priori knowledge of the errors involved with each observed parameter. | 02-23-2012 |
Jason L. Fein, Hastings On Hudson, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090203289 | Unit Block Toy Adapted to Compensate for Slight Size Variations - A unit block toy adapted to compensate for slight size variations can have a pair of opposed side walls adapted to be disposed over at least a portion of the unit block, and a gasket disposed on an inside surface of at least one of the pair of opposed side walls, the gasket being adapted to compensate for slight size variations. The gasket can have a concave side and a convex side, the concave side positioned adjacent the inside surface of the adjacent sidewall such that a space is formed between the gasket and the inside surface to permit adjustment for size variations via displacement of the membrane towards the inside surface. A slot can be provided in the inside surface of the side walls in which to dispose the gasket. | 08-13-2009 |
Lance Fein, Davie, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20100217728 | Multiproduct Advertising Development and Exposure - Innoventions Inc. a corporation in the state of Florida has developed a new method of multimedia advertising and marketing to mass markets. In today's economic climate, businesses need to find a model that increases their exposure to consumers without a respective cost increase. This is a unique method of multiproduct advertising development and exposure. The concept is designed to decrease the high cost of advertising to corporations or sellers without decreasing the effectiveness of the advertisement. | 08-26-2010 |
Marcia Fein US
| Patent application number | Description | Published |
|---|---|---|
| 20110066015 | OXIMETER SENSOR WITH DIGITAL MEMORY ENCODING PATIENT DATA - The present invention provides a memory chip for use in an oximeter sensor, or an associated adapter or connector circuit. The memory chip allows the storing of patient related data, such as patient trending data or a patient ID, to provide enhanced capabilities for the oximeter sensor. In addition to providing unique data to store in such a memory, the present invention include unique uses of the data stored in such a memory. | 03-17-2011 |
Michael Fein, Grayslake, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080231458 | RFID TAG WITH REDUCED DETUNING CHARACTERISTICS - An RFID tag and an RFID access card configured to reduce detuning effects from a typical RFID environment. The present invention provides an RFID tag that is specifically configured to reduce the detuning effects caused by initiating communication between an RFID tag and an RFID tag reader in the presence of materials such as metal, liquid, and the human body. In one embodiment, the present invention provides an RFID tag comprising an electronic circuit portion attached to a main antenna body portion, the main antenna body portion having two opposite side portions, which are substantially symmetrical with respect to one another, wherein each side portion extends outwardly to form a generally side-oriented v-shape. | 09-25-2008 |
| 20110115611 | ENCODING MODULE, ASSOCIATED ENCODING ELEMENT, CONNECTOR, PRINTER-ENCODER AND ACCESS CONTROL SYSTEM - An encoding module and related systems and components are provided. The encoding module includes a plurality of encoding elements arranged in an array of columns and rows and one or more switching elements configured to selectively connect the encoding elements to a reader. The connection of the encoding elements may be based on the location of a targeted transponder disposed among multiple adjacent transponders to ensure the selective communication with the targeted transponder only. The module is configured for various types and locations transponders to be used within a system, such as a printer-encoder. Each encoding element may include a loaded conductive strip comprising a loop shape portion and a shield that corresponds to the loop shape portion. In another embodiment, an access control system having an encoding module with the plurality of couplers and an access card having a plurality of transponders corresponding to the couplers is provided. | 05-19-2011 |
| 20110266352 | RFID TAG WITH REDUCED DETUNING CHARACTERISTICS - An RFID tag and an RFID access card configured to reduce detuning effects from a typical RFID environment. The present invention provides an RFID tag that is specifically configured to reduce the detuning effects caused by initiating communication between an RFID tag and an RFID tag reader in the presence of materials such as metal, liquid, and the human body. In one embodiment, the present invention provides an RFID tag comprising an electronic circuit portion attached to a main antenna body portion, the main antenna body portion having two opposite side portions, which are substantially symmetrical with respect to one another, wherein each side portion extends outwardly to form a generally side-oriented v-shape. | 11-03-2011 |
| 20120019363 | DUAL TRANSPONDER RADIO FREQUENCY IDENTIFICATION - Embodiments are discussed herein related to radio frequency identification (“RFID”) and, more particularly, to systems, methods, apparatuses, computer readable media products and other means for integrating two transponders into a tag, where each transponder functions independent from and does not couple with the other transponder. In some embodiments, one of the transponders can be a near field RFID transponder and the other a far field transponder. The near field RFID transponder can be used to, among other things, authenticate the far field RFID transponder. In some embodiments, the far field RFID transponder can be encoded to transmit generic information, while the near field RFID transmits more detailed or user-specific information. Additionally, in some embodiments, the near field and far field RFID transponders can operate in accordance with the same wireless protocol and include their own circuitry and antenna. | 01-26-2012 |
Rebecca Fein, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090018873 | Deferred Premium Annuities - Deferred premium annuities and accompanying methods are described herein. In some instances, a deferred premium annuity allows a purchaser (e.g., an individual) to pledge assets rather than pay cash up front to purchase an annuity. In these instances, an annuity provider then issues an annuity to the purchaser. In some instances, the provider then may then receive ownership of or an interest in the pledged assets upon death of the purchaser unless the purchaser pays for the annuity before the death of the purchaser. | 01-15-2009 |
| 20090037232 | Loans Collateralized by Life Insurance Policies - This document describes techniques pertaining to loans collateralized by life insurance policies. | 02-05-2009 |
Seymour Fein, New Canaan, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090042970 | METHODS AND DEVICES FOR DESMOPRESSIN DRUG DELIVERY - Disclosed are devices for urine voiding postponement, and methods for treating conditions such as central diabetes insipidus, enuresis, nocturia, urinary frequency or incontinence. The devices deliver a desmopressin flux through the skin of a patient in a low dose amount just necessary to achieve a desired anti-diuretic effect without undesirable side effects such as hyponatremia. The devices are designed to permit a state of normal urinary production to return quickly after the desmopressin flux is terminated. | 02-12-2009 |
| 20100056436 | Pharmaceutical Compositions Including Low Dosages of Desmopressin - The present invention is directed to a pharmaceutical composition comprising 0.5 ng to 20 μg desmopressin and a pharmaceutically acceptable carrier. The present invention is also directed to a pharmaceutical composition comprising desmopressin and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is effective to establish a steady plasma/serum desmopressin concentration in the range of from about 0.1 picograms desmopressin per mL plasma/serum to about 10.0 picogram desmopressin per mL plasma/serum. Articles of manufacture and methods of using the above invention are also disclosed. | 03-04-2010 |
| 20100160214 | DESMOPRESSIN COMPOSITION - Disclosed is a pharmaceutical formulation that may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control. | 06-24-2010 |
| 20120015880 | INTRANASAL DESMOPRESSIN ADMINISTRATION - Disclosed is a family of intranasal spray dispensers for administering uniform low doses of desmopressin so as to achieve safe antidiuresis in human patients. The dispensers of the invention may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control. | 01-19-2012 |
Seymour H. Fein, New Canaan, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20080274951 | PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN - The present invention is directed to a pharmaceutical composition comprising 0.5 ng to 20 μg desmopressin and a pharmaceutically acceptable carrier. The present invention is also directed to a pharmaceutical composition comprising desmopressin and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is effective to establish a steady plasma/serum desmopressin concentration in the range of from about 0.1 picograms desmopressin per mL plasma/serum to about 10.0 picogram desmopressin per mL plasma/serum. Articles of manufacture and methods of using the above invention are also disclosed. | 11-06-2008 |
| 20090005432 | PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN - The present invention is directed to a pharmaceutical composition comprising 0.5 ng to 20 μg desmopressin and a pharmaceutically acceptable carrier. The present invention is also directed to a pharmaceutical composition comprising desmopressin and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is effective to establish a steady plasma/serum desmopressin concentration in the range of from about 0.1 picograms desmopressin per mL plasma/serum to about 10.0 picogram desmopressin per mL plasma/serum. Articles of manufacture and methods of using the above invention are also disclosed. | 01-01-2009 |